Concomitant use of imatinib and warfarin in chronic phase chronic myeloid leukemia patients does not interfere with drug efficacy

Leuk Res. 2010 Aug;34(8):e224-5. doi: 10.1016/j.leukres.2010.03.015. Epub 2010 Mar 30.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Anticoagulants / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Benzamides
  • Drug Therapy, Combination
  • Female
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Male
  • Middle Aged
  • Piperazines / therapeutic use*
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Pyrimidines / therapeutic use*
  • Treatment Outcome
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Warfarin
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases